210 related articles for article (PubMed ID: 8222147)
1. Detection of intraluminal release of endothelium-derived relaxing factor from human saphenous veins.
Chua YL; Pearson PJ; Evora PR; Schaff HV
Circulation; 1993 Nov; 88(5 Pt 2):II128-32. PubMed ID: 8222147
[TBL] [Abstract][Full Text] [Related]
2. Production of endothelium-dependent relaxation responses by saphenous vein grafts in the canine arterial circulation.
el Khatib H; Lupinetti FM; Sanofsky SJ; Behrendt DM
Surgery; 1991 Sep; 110(3):523-8. PubMed ID: 1887376
[TBL] [Abstract][Full Text] [Related]
3. Endothelium-dependent relaxation in human saphenous vein grafts. Effects of preparation and clinicopathologic correlations.
Lawrie GM; Weilbacher DE; Henry PD
J Thorac Cardiovasc Surg; 1990 Oct; 100(4):612-20. PubMed ID: 2120519
[TBL] [Abstract][Full Text] [Related]
4. Bioassay of EDRF from internal mammary arteries: implications for early and late bypass graft patency.
Pearson PJ; Evora PR; Schaff HV
Ann Thorac Surg; 1992 Dec; 54(6):1078-84. PubMed ID: 1449290
[TBL] [Abstract][Full Text] [Related]
5. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
Blaise GA; Stewart DJ; Guérard MJ
Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia increases vasodilator release from internal mammary artery and saphenous vein grafts.
Pearson PJ; Evora PR; Discigil B; Schaff HV
Ann Thorac Surg; 1998 May; 65(5):1220-5. PubMed ID: 9594841
[TBL] [Abstract][Full Text] [Related]
7. Constitutive nitric oxide synthase is expressed and nitric oxide-mediated relaxation is preserved in retrieved human aortocoronary vein grafts.
Davies MG; Berkowitz DE; Hagen PO
J Surg Res; 1995 Jun; 58(6):732-8. PubMed ID: 7540701
[TBL] [Abstract][Full Text] [Related]
8. Recombinant endothelial nitric oxide synthase-transduced human saphenous veins: gene therapy to augment nitric oxide production in bypass conduits.
Cable DG; O'Brien T; Schaff HV; Pompili VJ
Circulation; 1997 Nov; 96(9 Suppl):II-173-8. PubMed ID: 9386094
[TBL] [Abstract][Full Text] [Related]
9. Functional changes in canine saphenous veins after cryopreservation.
Elmore JR; Gloviczki P; Brockbank KG; Miller VM
Int Angiol; 1992; 11(1):26-35. PubMed ID: 1522350
[TBL] [Abstract][Full Text] [Related]
10. Effects of lumbar sympathectomy on the properties of both endothelium and smooth muscle cells of the canine femoral artery and autogenous vein grafts under poor runoff conditions.
Funahashi S; Komori K; Itoh H; Okadome K; Sugimachi K
J Surg Res; 1996 Aug; 64(2):184-9. PubMed ID: 8812631
[TBL] [Abstract][Full Text] [Related]
11. Endothelium-dependent regulatory mechanisms in human coronary bypass grafts: possible clinical implications.
Yang Z; Lüscher TF
Z Kardiol; 1989; 78 Suppl 6():80-4. PubMed ID: 2575830
[TBL] [Abstract][Full Text] [Related]
12. Endothelial function of human gastroepiploic artery. Implications for its use as a bypass graft.
O'Neil GS; Chester AH; Allen SP; Luu TN; Tadjkarimi S; Ridley P; Khagani A; Musumeci F; Yacoub MH
J Thorac Cardiovasc Surg; 1991 Oct; 102(4):561-5. PubMed ID: 1717794
[TBL] [Abstract][Full Text] [Related]
13. Effects of basal and acetylcholine-induced release of endothelium-derived relaxing factor on contraction to alpha-adrenoceptor agonists in a rabbit artery and corresponding veins.
McGrath JC; Monaghan S; Templeton AG; Wilson VG
Br J Pharmacol; 1990 Jan; 99(1):77-86. PubMed ID: 1970495
[TBL] [Abstract][Full Text] [Related]
14. Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts.
Lüscher TF; Diederich D; Siebenmann R; Lehmann K; Stulz P; von Segesser L; Yang ZH; Turina M; Grädel E; Weber E
N Engl J Med; 1988 Aug; 319(8):462-7. PubMed ID: 3136329
[TBL] [Abstract][Full Text] [Related]
15. Hypothermic storage with University of Wisconsin solution preserves endothelial and vascular smooth-muscle function.
Sorajja P; Cable DG; Schaff HV
Circulation; 1997 Nov; 96(9 Suppl):II-297-302; discussion II-302-3. PubMed ID: 9386114
[TBL] [Abstract][Full Text] [Related]
16. The human internal thoracic artery releases more nitric oxide in response to vascular endothelial growth factor than the human saphenous vein.
Broeders MA; Doevendans PA; Maessen JG; van Gorsel E; Egbrink MG; Daemen MJ; Tangelder GJ; Reneman RS; van der Zee R
J Thorac Cardiovasc Surg; 2001 Aug; 122(2):305-9. PubMed ID: 11479503
[TBL] [Abstract][Full Text] [Related]
17. Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein.
Tanner FC; Largiadèr T; Greutert H; Yang Z; Lüscher TF
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):20-6. PubMed ID: 14752408
[TBL] [Abstract][Full Text] [Related]
18. Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit.
Amerini S; Filippi S; Parenti A; Ledda F; Ziche M
Br J Pharmacol; 1997 Dec; 122(8):1739-45. PubMed ID: 9422822
[TBL] [Abstract][Full Text] [Related]
19. The release of the endothelium derived relaxing factor from isolated human arteries.
Thom SA; Hughes AD; Martin GN; Sever PS
J Hypertens Suppl; 1985 Dec; 3(3):S97-9. PubMed ID: 2856828
[TBL] [Abstract][Full Text] [Related]
20. Effects of leukotrienes C4 and D4 on human isolated saphenous veins.
Allen SP; Chester AH; Piper PJ; Sampson AP; Akl ES; Yacoub MH
Br J Clin Pharmacol; 1992 Nov; 34(5):409-14. PubMed ID: 1467135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
